Overview

Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery

Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of BCT197 on acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass.
Phase:
Phase 2
Details
Lead Sponsor:
Mereo BioPharma
Novartis Pharmaceuticals
Collaborator:
Novartis